KOI (2).pngA Not-to-Miss White Paper from AHM

Key Opinion Leaders (KOLs), also known as thought leaders, are physicians; healthcare professionals whose expertise, reputation and professional following is used by the Life Sciences industry to provide knowledgeable research and support on therapies, both old and new throughout the drug development process.

Download this white paper and learn about:

  • Key approaches to engage KOLs
  • Regulations affecting KOLs globally
  • How to select a KOL
  • And more
AHM-landing-image.png

A 5-Year Industry Trend Analysis

AHM continually monitors key trends and statistics in the Life Sciences Industry. This 5-year analysis reveals that live programming and HCP attendance are robust, despite fewer drug approvals and Open Payments reporting.  Download this white paper and discover:

 

  • A better understanding of trends associated with the management and execution of promotional speaker programs.
  • The average attendance per program, cost per program, and spend by attendee type over the past 5 years
  • Important industry benchmarks
  • And more
executive-perspective.png

The culture of HCP Engagement and Speaker Programs has changed dramatically over the years with the dramatic growth of regulation and compliance. Each compliance mandate was aimed at making the relations between the industry and HCPs more transparent and each brought to bear the triad of public opinion, potentially painful penalties, and a new focus on compliance as a key corporate value.

 

In this white paper, AHM’s Peter Collins discusses how compliance impacts HCP engagements, and steps that Life Sciences companies can take to improve their speaker program efforts.

HPME-2.png
This  benchmarking survey was conducted by Penton Research, parent company of MeetingsNet, with AHM. The respondents included more than 100 organizations leading the Life Sciences industry today. This ground breaking report looks at the findings through a Life Sciences lens, highlighting areas of opportunity to improve compliance, centralize data, consolidate vendors, & leverage buying power.

 

The data provides a deeper understanding of how Life Sciences companies manage HCP engagements in terms of compliance and procurement.